Showing results (291-300 of 381) with videos related to
Sort By:
Pageof 39
Annals of Surgery|February 2, 2023
Radical Resection Combined With Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy: A Report of 36 Consecutive CasesTingbo Liang, Qi Zhang, Guosheng Wu, et al.Molecular Oncology|June 28, 2020
Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasisTao Wei, Jian Zhang, Jin Li, et al.Infectious Microbes & Diseases|June 6, 2025
Translation: Management of Coronavirus Disease 2019 (COVID-19): Experience in Zhejiang Province, ChinaKaijin Xu, Hongliu Cai, Yihong Shen, et al.Nature|February 25, 2026
Pancreatic-targeted lipid nanoparticles based on organ capsule filtrationJiaqi Lei, Kai Yang, Wanyue Cao, et al.Signal Transduction and Targeted Therapy|March 24, 2023
Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemiaLijing Wang, Shuchen Gu, Fenfang Chen, et al.Molecular Cell|November 10, 2020
TBK1-Mediated DRP1 Targeting Confers Nucleic Acid Sensing to Reprogram Mitochondrial Dynamics and PhysiologyShasha Chen, Shengduo Liu, Junxian Wang, et al.Cell Reports|October 9, 2025
pORF3-driven biogenesis of lipid droplets facilitates HEV infectivityLing-Dong Xu, Fei Zhang, Can Miao, et al.Journal of Hepatology|December 27, 2022
Targeting proteostasis of the HEV replicase to combat infection in preclinical modelsFei Zhang, Ling-Dong Xu, Qian Zhang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2025
Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activationZhe Zhang, Qitai Chen, Rujia Zheng, et al.Signal Transduction and Targeted Therapy|October 9, 2024
Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II studyYiwen Chen, Junlei Zhang, Wendi Hu, et al.Pageof 39